Form 8-K - Current report:
SEC Accession No. 0001213900-25-068990
Filing Date
2025-07-30
Accepted
2025-07-30 10:02:36
Documents
12
Period of Report
2025-07-30
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0250767-8k_biomx.htm   iXBRL 8-K 22795
  Complete submission text file 0001213900-25-068990.txt   186945

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20250730.xsd EX-101.SCH 3005
3 XBRL LABEL FILE phge-20250730_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE phge-20250730_pre.xml EX-101.PRE 22352
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0250767-8k_biomx_htm.xml XML 3648
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 251164465
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)